179 related articles for article (PubMed ID: 32994277)
1. Relative Adipose Tissue Failure in Alström Syndrome Drives Obesity-Induced Insulin Resistance.
Geberhiwot T; Baig S; Obringer C; Girard D; Dawson C; Manolopoulos K; Messaddeq N; Bel Lassen P; Clement K; Tomlinson JW; Steeds RP; Dollfus H; Petrovsky N; Marion V
Diabetes; 2021 Feb; 70(2):364-376. PubMed ID: 32994277
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of the Alström syndrome-associated gene Alms1 in 3T3-L1 preadipocytes impairs adipogenesis but has no effect on cell-autonomous insulin action.
Huang-Doran I; Semple RK
Int J Obes (Lond); 2010 Oct; 34(10):1554-8. PubMed ID: 20514046
[TBL] [Abstract][Full Text] [Related]
3. Alström syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity.
Dassie F; Favaretto F; Bettini S; Parolin M; Valenti M; Reschke F; Danne T; Vettor R; Milan G; Maffei P
Endocrine; 2021 Mar; 71(3):618-625. PubMed ID: 33566311
[TBL] [Abstract][Full Text] [Related]
4. GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance.
Favaretto F; Milan G; Collin GB; Marshall JD; Stasi F; Maffei P; Vettor R; Naggert JK
PLoS One; 2014; 9(10):e109540. PubMed ID: 25299671
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal-specific Alms1 knockout in mice recapitulates metabolic features of Alström syndrome.
McKay EJ; Luijten I; Weng X; Martinez de Morentin PB; De Frutos González E; Gao Z; Kolonin MG; Heisler LK; Semple RK
Mol Metab; 2024 Jun; 84():101933. PubMed ID: 38583571
[TBL] [Abstract][Full Text] [Related]
6. Obesity-related hypoxia via miR-128 decreases insulin-receptor expression in human and mouse adipose tissue promoting systemic insulin resistance.
Arcidiacono B; Chiefari E; Foryst-Ludwig A; Currò G; Navarra G; Brunetti FS; Mirabelli M; Corigliano DM; Kintscher U; Britti D; Mollace V; Foti DP; Goldfine ID; Brunetti A
EBioMedicine; 2020 Sep; 59():102912. PubMed ID: 32739259
[TBL] [Abstract][Full Text] [Related]
7. Genomic knockout of alms1 in zebrafish recapitulates Alström syndrome and provides insight into metabolic phenotypes.
Nesmith JE; Hostelley TL; Leitch CC; Matern MS; Sethna S; McFarland R; Lodh S; Westlake CJ; Hertzano R; Ahmed ZM; Zaghloul NA
Hum Mol Genet; 2019 Jul; 28(13):2212-2223. PubMed ID: 31220269
[TBL] [Abstract][Full Text] [Related]
8. PATAS, a First-in-Class Therapeutic Peptide Biologic, Improves Whole-Body Insulin Resistance and Associated Comorbidities In Vivo.
Schreyer E; Obringer C; Messaddeq N; Kieffer B; Zimmet P; Fleming A; Geberhiwot T; Marion V
Diabetes; 2022 Sep; 71(9):2034-2047. PubMed ID: 35822820
[TBL] [Abstract][Full Text] [Related]
9. Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alstrom syndrome.
Minton JA; Owen KR; Ricketts CJ; Crabtree N; Shaikh G; Ehtisham S; Porter JR; Carey C; Hodge D; Paisey R; Walker M; Barrett TG
J Clin Endocrinol Metab; 2006 Aug; 91(8):3110-6. PubMed ID: 16720663
[TBL] [Abstract][Full Text] [Related]
10. DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity.
Romacho T; Sell H; Indrakusuma I; Roehrborn D; Castañeda TR; Jelenik T; Markgraf D; Hartwig S; Weiss J; Al-Hasani H; Roden M; Eckel J
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E590-E599. PubMed ID: 31891536
[TBL] [Abstract][Full Text] [Related]
11. Genetic identification of thiosulfate sulfurtransferase as an adipocyte-expressed antidiabetic target in mice selected for leanness.
Morton NM; Beltram J; Carter RN; Michailidou Z; Gorjanc G; McFadden C; Barrios-Llerena ME; Rodriguez-Cuenca S; Gibbins MT; Aird RE; Moreno-Navarrete JM; Munger SC; Svenson KL; Gastaldello A; Ramage L; Naredo G; Zeyda M; Wang ZV; Howie AF; Saari A; Sipilä P; Stulnig TM; Gudnason V; Kenyon CJ; Seckl JR; Walker BR; Webster SP; Dunbar DR; Churchill GA; Vidal-Puig A; Fernandez-Real JM; Emilsson V; Horvat S
Nat Med; 2016 Jul; 22(7):771-9. PubMed ID: 27270587
[TBL] [Abstract][Full Text] [Related]
12. COL6A3 expression in adipocytes associates with insulin resistance and depends on PPARγ and adipocyte size.
Dankel SN; Svärd J; Matthä S; Claussnitzer M; Klöting N; Glunk V; Fandalyuk Z; Grytten E; Solsvik MH; Nielsen HJ; Busch C; Hauner H; Blüher M; Skurk T; Sagen JV; Mellgren G
Obesity (Silver Spring); 2014 Aug; 22(8):1807-13. PubMed ID: 24719315
[TBL] [Abstract][Full Text] [Related]
13. The progression from obesity to type 2 diabetes in Alström syndrome.
Bettini V; Maffei P; Pagano C; Romano S; Milan G; Favaretto F; Marshall JD; Paisey R; Scolari F; Greggio NA; Tosetto I; Naggert JK; Sicolo N; Vettor R
Pediatr Diabetes; 2012 Feb; 13(1):59-67. PubMed ID: 21722283
[TBL] [Abstract][Full Text] [Related]
14. Alström syndrome: Renal findings in correlation with obesity, insulin resistance, dyslipidemia and cardiomyopathy in 38 patients prospectively evaluated at the NIH clinical center.
Waldman M; Han JC; Reyes-Capo DP; Bryant J; Carson KA; Turkbey B; Choyke P; Naggert JK; Gahl WA; Marshall JD; Gunay-Aygun M
Mol Genet Metab; 2018 Sep; 125(1-2):181-191. PubMed ID: 30064963
[TBL] [Abstract][Full Text] [Related]
15. Loss of BMP receptor type 1A in murine adipose tissue attenuates age-related onset of insulin resistance.
Schulz TJ; Graja A; Huang TL; Xue R; An D; Poehle-Kronawitter S; Lynes MD; Tolkachov A; O'Sullivan LE; Hirshman MF; Schupp M; Goodyear LJ; Mishina Y; Tseng YH
Diabetologia; 2016 Aug; 59(8):1769-77. PubMed ID: 27209464
[TBL] [Abstract][Full Text] [Related]
16. Adipocyte insulin receptor activity maintains adipose tissue mass and lifespan.
Friesen M; Hudak CS; Warren CR; Xia F; Cowan CA
Biochem Biophys Res Commun; 2016 Aug; 476(4):487-492. PubMed ID: 27246738
[TBL] [Abstract][Full Text] [Related]
17. SOD3 Is Secreted by Adipocytes and Mitigates High-Fat Diet-Induced Obesity, Inflammation, and Insulin Resistance.
Gao D; Hu S; Zheng X; Lin W; Gao J; Chang K; Zhao D; Wang X; Zhou J; Lu S; Griffiths HR; Liu J
Antioxid Redox Signal; 2020 Jan; 32(3):193-212. PubMed ID: 31680537
[No Abstract] [Full Text] [Related]
18. Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial.
Baig S; Veeranna V; Bolton S; Edwards N; Tomlinson JW; Manolopoulos K; Moran J; Steeds RP; Geberhiwot T
BMC Endocr Disord; 2018 Nov; 18(1):88. PubMed ID: 30477455
[TBL] [Abstract][Full Text] [Related]
19. Glucose-6-Phosphate Dehydrogenase Deficiency Improves Insulin Resistance With Reduced Adipose Tissue Inflammation in Obesity.
Ham M; Choe SS; Shin KC; Choi G; Kim JW; Noh JR; Kim YH; Ryu JW; Yoon KH; Lee CH; Kim JB
Diabetes; 2016 Sep; 65(9):2624-38. PubMed ID: 27284106
[TBL] [Abstract][Full Text] [Related]
20. Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver.
Kim K; Kang JK; Jung YH; Lee SB; Rametta R; Dongiovanni P; Valenti L; Pajvani UB
Nat Commun; 2021 Mar; 12(1):1822. PubMed ID: 33758172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
